In conclusion, individuals with NAFLD who increase erythrocyte DHA enrichment (⩾2% as a marker for tissue enrichment) show notable changes in hepatic insulin sensitivity and hepatic FA metabolism that favour decreased hepatic DNL and increased hepatic FA oxidation which would be expected to decrease hepatic TG synthesis and storage. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.